Disease groups of interest
This section presents detailed summaries for disease groups of interest for the First Nations population, including changes since 2011. These disease groups include mental health conditions & substance use disorders, injuries, cardiovascular diseases, endocrine disorders, and kidney & urinary diseases. Each of these are disease groups make a substantial or disproportionate contribution to the burden of disease of First Nations people.
Before reading this section it is recommended to first read earlier sections of this report which provide a high level overview of total burden, non-fatal burden and fatal burden in the First Nations population. Information on the quality of estimates is included in Australian Burden of Disease Study: methods and supplementary material 2018.
This section of the report will be updated once data on risk factor attributable burden is available, to include a summary of the cancer & other neoplasms disease group and risk factor attributable burden for each disease group.
To explore data across all disease groups, see the following data visualisations:
- Dashboard 1: Burden of disease in Australia: This visualisation provides total, fatal and non-fatal burden numbers and rates both overall and for each disease group by sex and age
- Dashboard 2: Fatal vs. non-fatal burden: This visualisation shows the distribution of fatal and non-fatal burden by year, sex, age group and disease group.
- Dashboard 3: Comparisons over time: This visualisation presents comparisons of age-standardised and age-specific rates of total, fatal and non-fatal burden by year, sex and disease group.
- Dashboards 6a and 6b: Gap in health outcomes: These visualisations present the contribution of disease groups to the gap, by year, age and sex. They also show the DALY rate ratios and rate differences by disease group.
- Dashboard 7: Top disease groups across the stages of life: This visualisation shows the top 5 disease groups contributing to burden for each age group and the top specific causes contributing to those disease groups disaggregated by fatal and non-fatal burden.